AAAAAA

   
Results: 1-14 |
Results: 14
Diffuse large B-cell lymphoma with primary retroperitoneal presentation: Clinico-pathologic study of nine cases
Authors: Pileri, SA Zinzani, PL Ascani, S Orcioni, GF Gamberi, B Piccioli, M Sabattini, E Poggi, S Piccaluga, PP Falini, B
Citation: Sa. Pileri et al., Diffuse large B-cell lymphoma with primary retroperitoneal presentation: Clinico-pathologic study of nine cases, ANN ONCOL, 12(10), 2001, pp. 1445-1453
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia - analysis of 848 patients
Authors: Visani, G Bernasconi, P Boni, M Castoldi, GL Ciolli, S Clavio, M Cox, MC Cuneo, A Del Poeta, G Dini, D Falzetti, D Fanin, R Gobbi, M Isidori, A Leoni, F Liso, V Malagola, M Martinelli, G Mecucci, C Piccaluga, PP Petti, MC Rondelli, R Russo, D Sessarego, M Specchia, G Testoni, N Torelli, G Mandelli, F Tura, S
Citation: G. Visani et al., The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia - analysis of 848 patients, LEUKEMIA, 15(6), 2001, pp. 903-909
Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia
Authors: Visani, G Milligan, D Leoni, F Chang, J Kelsey, S Marcus, R Powles, R Schey, S Covelli, A Isidori, A Litchman, M Piccaluga, PP Mayer, H Malagola, M Pfister, C
Citation: G. Visani et al., Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia, LEUKEMIA, 15(5), 2001, pp. 764-771
Pulsed ATRA as single therapy restores long-term remission in PML-RAR alpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study
Authors: Visani, G Buonamici, S Malagola, M Isidori, A Piccaluga, PP Martinelli, G Ottaviani, E Grafone, T Baccarani, M Tura, S
Citation: G. Visani et al., Pulsed ATRA as single therapy restores long-term remission in PML-RAR alpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study, LEUKEMIA, 15(11), 2001, pp. 1696-1700
Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients
Authors: Visani, G Lemoli, RM Isidori, A Piccaluga, PP Martinelli, G Malagola, M Gugliotta, L Bonini, A Bonifazi, F Motta, MR Rizzi, S Castellani, S Tura, S
Citation: G. Visani et al., Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients, BONE MAR TR, 27(8), 2001, pp. 829-835
Myeloperoxidase expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathy
Authors: Pileri, SA Facchetti, F Ascani, S Sabattini, E Poggi, S Piccioli, M Rondelli, D Vergoni, F Zinzani, PL Piccaluga, PP Falini, B Isaacson, PG
Citation: Sa. Pileri et al., Myeloperoxidase expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathy, AM J PATH, 159(3), 2001, pp. 915-924
Chemotherapy of secondary leukemias
Authors: Visani, G Pagano, L Pulsoni, A Tosi, P Piccaluga, PP Pastano, R Grafone, T Malagola, M Isidori, A Tura, S
Citation: G. Visani et al., Chemotherapy of secondary leukemias, LEUK LYMPH, 37(5-6), 2000, pp. 543-549
Efficacy of rituximab in hairy cell leukemia treatment
Authors: Zinzani, PL Ascani, S Piccaluga, PP Bendandi, M Pileri, S Tura, S
Citation: Pl. Zinzani et al., Efficacy of rituximab in hairy cell leukemia treatment, J CL ONCOL, 18(22), 2000, pp. 3875-3877
Value of gemcitabine treatment in heavily pretreated Hodgkin's disease patients
Authors: Zinzani, PL Bendandi, M Stefoni, V Albertini, P Gherlinzoni, F Tani, M Piccaluga, PP Tura, S
Citation: Pl. Zinzani et al., Value of gemcitabine treatment in heavily pretreated Hodgkin's disease patients, HAEMATOLOG, 85(9), 2000, pp. 926-929
Anaplastic lymphoma kinase expression as a marker of malignancy Application to a case of anaplastic large cell lymphoma with huge granulomatous reaction
Authors: Piccaluga, PP Ascani, S Orcioni, GF Piccioli, M Pileri, A Falini, B Pileri, SA
Citation: Pp. Piccaluga et al., Anaplastic lymphoma kinase expression as a marker of malignancy Application to a case of anaplastic large cell lymphoma with huge granulomatous reaction, HAEMATOLOG, 85(9), 2000, pp. 978-981
The pathologist's view point. Part I - indolent lymphomas
Authors: Pileri, SA Ascani, S Sabatini, E Fraternali-Orcioni, G Poggi, S Piccioli, M Piccaluga, PP Gamberi, B Zinzani, PL Leoncini, L Falini, B
Citation: Sa. Pileri et al., The pathologist's view point. Part I - indolent lymphomas, HAEMATOLOG, 85(12), 2000, pp. 1291-1307
The pathologist's view point. Part II - aggressive lymphomas
Authors: Pileri, SA Ascani, S Sabattini, E Fraternali-Orcioni, G Poggi, S Piccoli, M Piccaluga, PP Gamberi, B Zinzani, PL Leoncini, L Falini, B
Citation: Sa. Pileri et al., The pathologist's view point. Part II - aggressive lymphomas, HAEMATOLOG, 85(12), 2000, pp. 1308-1321
Use of peripheral blood stem cells for autologous transplantation in acutemyeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells
Authors: Visani, G Lemoli, RM Tosi, P Martinelli, G Testoni, N Ricci, P Motta, MR Gherlinzoni, F Leopardi, G Pastano, R Rizzi, S Piccaluga, PP Isidori, A Tura, S
Citation: G. Visani et al., Use of peripheral blood stem cells for autologous transplantation in acutemyeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells, BONE MAR TR, 24(5), 1999, pp. 467-472
Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients
Authors: Visani, G Lemoli, RM Tosi, P Martinelli, G Testoni, N Ricci, P Piccaluga, PP Pastano, R Leopardi, G Dizdari, A Motta, MR Rizzi, S Tura, S
Citation: G. Visani et al., Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients, BR J HAEM, 105(3), 1999, pp. 775-779
Risultati: 1-14 |